News for 'Dr Reddy'

Another bull run on D-Street; Sensex, Nifty at new peaks

Another bull run on D-Street; Sensex, Nifty at new peaks

Rediff.com18 Oct 2021

Infosys was the top gainer in the Sensex pack, jumping over 4 per cent, followed by Tech Mahindra, Tata Steel, ICICI Bank, ITC, Maruti, SBI and Axis Bank. On the other hand, HCL Tech, M&M, Dr Reddy's, Asian Paints, Bajaj Auto and Bharti Airtel were among the laggards.

Markets spurt over 1%; Sensex gains 712 points

Markets spurt over 1%; Sensex gains 712 points

Rediff.com29 Jul 2022

Benchmark indices continued to rally for the third day running on Friday with the Sensex climbing 619 points in early trade to reclaim the 57,000 level. The 30-share BSE benchmark jumped 619.27 points to 57,477.06. The broader NSE Nifty advanced 189.15 points to 17,118.75.

Sensex, Nifty drop nearly 1% on global recession fears

Sensex, Nifty drop nearly 1% on global recession fears

Rediff.com26 Jul 2022

Benchmark BSE Sensex and Nifty closed lower by nearly 1 per cent on Tuesday amid fresh foreign fund outflows and mixed global trends. The 30-share BSE benchmark fell by 497.73 points or 0.89 per cent to settle at 55,268.49, extending its losses for second straight day. During the day, it tanked 562.79 points or 1 per cent to 55,203.43. The broader NSE Nifty declined by 147.15 points or 0.88 per cent to 16,483.85.

The chakravyuh of the RBI governor's job

The chakravyuh of the RBI governor's job

Rediff.com10 Dec 2018

The friction with the political class is not only about interest rates and monetary policy. While the government often spoke freely about its discomfiture, the RBI had to be careful even in its response to the government as any loose statement would affect the markets.

Investors' wealth rises Rs 5.66 lakh crore as equity markets rebound

Investors' wealth rises Rs 5.66 lakh crore as equity markets rebound

Rediff.com4 Oct 2022

Equity investors became richer by Rs 5.66 lakh crore as markets bounced back sharply on Tuesday following a recovery in global equities. The 30-share BSE Sensex jumped 1,276.66 points or 2.25 per cent to settle at 58,065.47 points. During the day, it zoomed 1,311.13 points or 2.30 per cent to 58,099.94 points. The market capitalisation of BSE-listed firms climbed Rs 566,318.84 crore to Rs 273,92,739.78 crore.

Sensex pares early gains as IT stocks crack

Sensex pares early gains as IT stocks crack

Rediff.com9 Dec 2022

Equity benchmark Sensex declined nearly 390 points on Friday, pressured by heavy selling in IT, tech and energy stocks despite a positive trend in the global markets. Besides, rising crude oil prices and relentless foreign capital outflows further weighed on sentiment, traders said. The 30-share BSE Sensex opened strong but came under severe selling pressure to close 389.01 points or 0.62 per cent lower at 62,181.67.

Sensex pares losses; finally ends down 581 pts on weak global cue

Sensex pares losses; finally ends down 581 pts on weak global cue

Rediff.com27 Jan 2022

HCL Tech was the top loser in the Sensex pack, skidding over 4 per cent, followed by Tech Mahindra Dr Reddy's, Wipro, TCS, Titan and Infosys. NSE Nifty plunged 167.80 points to 17,110.15.

Jayalalithaa's death: TN panel indicts Sasikala, govt prepares for action

Jayalalithaa's death: TN panel indicts Sasikala, govt prepares for action

Rediff.com18 Oct 2022

The Justice A Arumughaswamy Commission of Inquiry that probed the circumstances leading to Jayalalithaa's death in 2016, in its concluding remarks said that V K Sasikala, the late Chief Minister's confidante, 'have to be found fault with and investigation is to be ordered'.

Full list: Modi's New Ministers And Their Portfolios

Full list: Modi's New Ministers And Their Portfolios

Rediff.com10 Jun 2024

Here is the complete list of ministers in Modi 3.0 and their portfolios:

Excise policy: ED arrests BRS leader Kavitha after raid; taken to Delhi

Excise policy: ED arrests BRS leader Kavitha after raid; taken to Delhi

Rediff.com15 Mar 2024

BRS leader and former Telangana minister Vemula Prashanth Reddy claimed that Kavitha was taken to Delhi on a flight at 8.45 pm.

Sensex, Nifty rebound sharply after 4-day rout

Sensex, Nifty rebound sharply after 4-day rout

Rediff.com8 Mar 2022

From the 30-share pack, Sun Pharma, TCS, Tech Mahindra, NTPC, Wipro, UltraTech Cement, Dr Reddy's Laboratories and Infosys were the major gainers, jumping up to 3.99 per cent. In contrast, Tata Steel, Nestle, Titan Company, PowerGrid, Reliance Industries Limited and State Bank of India were among the laggards.

RIL, ITC, Kotak Bank drag Sensex down by 166 points

RIL, ITC, Kotak Bank drag Sensex down by 166 points

Rediff.com14 Dec 2021

ITC was the top loser in the Sensex pack, shedding nearly 3 per cent, followed by Bajaj Finance, Kotak Bank, Bharti Airtel and Reliance Industries. Nifty fell 43.35 points to 17,324.90.

Sensex gains 345 points at close; FMCG, auto shares shine

Sensex gains 345 points at close; FMCG, auto shares shine

Rediff.com15 Jul 2022

Benchmark BSE Sensex rebounded by 344 points while Nifty closed above the 16,000 level in choppy trade on Friday, snapping the four-day falling streak on renewed buying interest from foreign funds and firm global trends. The 30-share BSE barometer climbed 344.63 points or 0.65 per cent to settle at 53,760.78. During the day, it jumped 395.22 points or 0.73 per cent to 53,811.37.

Sensex tanks 202 pts as Covid surge continued to weigh on investors sentiments

Sensex tanks 202 pts as Covid surge continued to weigh on investors sentiments

Rediff.com23 Apr 2021

M&M was the top loser in the Sensex pack, shedding over 2 per cent, followed by Dr Reddy's Bharti Airtel, Tech Mahindra, HUL, ICICI Bank and Infosys. NSE Nifty dropped 64.80 points to 14,341.35.

Sarfaraz's First Reaction To India Call

Sarfaraz's First Reaction To India Call

Rediff.com30 Jan 2024

Sarfaraz's inclusion is well-deserved, backed by an exceptional performance in the unofficial Test match against England Lions,

Teva sues Indian pharma cos

Teva sues Indian pharma cos

Rediff.com4 Jul 2007

Teva Pharmaceutical Industries Ltd has sued Indian drug makers, including Ranbaxy Laboratories and Dr Reddy's, for alleged patent violation of ingredients used in Coreg, used for treatment of cardiovascular diseases.

Markets settle marginally higher on fag-end buying

Markets settle marginally higher on fag-end buying

Rediff.com18 Aug 2022

Equity benchmark Sensex gained 37 points on Thursday, tracking gains in index majors Kotak Bank, L&T and Bharti Airtel amid a largely negative trend in global markets. After a largely choppy session, the 30-share BSE index ended 37.87 points or 0.06 per cent higher at 60,298 after starting the trade on a weak note. During the day, it hit a high of 60,341.41 and a low of 59,946.44.

'Our risk is now being managed'

'Our risk is now being managed'

Rediff.com10 Mar 2006

The US continues to be the most important part of our overseas portfolio

DRL develops generic version of Lipitor

DRL develops generic version of Lipitor

Rediff.com7 Nov 2009

Dr Reddy's Laboratories has succeeded in developing a copycat or generic version of Pfizer's Lipitor, the world's largest selling drug which has sales of over $10 billion.

Sensex sinks 486 pts led by losses in index majors

Sensex sinks 486 pts led by losses in index majors

Rediff.com8 Jul 2021

Tata Steel was the top loser in the Sensex pack, shedding over 2 per cent, followed by Sun Pharma, ICICI Bank, SBI, Kotak Bank and Dr Reddy's. NSE Nifty dropped 151.75 points to 15,727.90.

Pharma majors shift slect production to India

Pharma majors shift slect production to India

Rediff.com28 May 2007

After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddy's Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to their Indian facilities.

Sensex, Nifty end in red on profit booking

Sensex, Nifty end in red on profit booking

Rediff.com4 Aug 2022

Equity benchmarks snapped their six-session rally to close marginally lower on Thursday amid profit booking in banking and energy counters. Investors also stayed on the sidelines ahead of the RBI's policy meet outcome on Friday. In choppy trade, the 30-share BSE Sensex ended 51.73 points or 0.09 per cent lower at 58,298.80. During the day, it hit a low of 57,577.05 and a high of 58,712.66.

'Oil remains a concern'

'Oil remains a concern'

Rediff.com21 Oct 2004

Otherwise markets would be okay..

Markets rally for 2nd day; Sensex jumps 1,041 points

Markets rally for 2nd day; Sensex jumps 1,041 points

Rediff.com28 Jul 2022

Benchmark indices rallied on Thursday with the Sensex and Nifty climbing nearly 2 per cent, helped by heavy buying in Bajaj Finance shares amid a mixed trend in the global equity markets. The 30-share BSE benchmark jumped 1,041.47 points or 1.87 per cent to settle at 56,857.79. During the day, it rallied 1,097.9 points or 1.96 per cent to 56,914.22. The broader NSE Nifty advanced 287.80 points or 1.73 per cent to 16,929.60.

Sensex climbs 284 points to settle at 55,682

Sensex climbs 284 points to settle at 55,682

Rediff.com21 Jul 2022

Benchmark indices bounced back after falling in early trade on Thursday and logged the fifth day of gain amid a decline in crude oil prices and foreign funds inflow. The 30-share BSE Sensex climbed 284.42 points or 0.51 per cent to settle at 55,681.95. During the day, it jumped 340.96 points or 0.61 per cent to 55,738.49. The broader NSE Nifty went higher by 84.40 points or 0.51 per cent to 16,605.25.

IT, oil, banking shares boost Sensex by 760 points

IT, oil, banking shares boost Sensex by 760 points

Rediff.com18 Jul 2022

Benchmark stock indices Sensex and Nifty spurted over 1 per cent at close on Monday following buying in IT, oil and gas and banking shares bolstered by firm global trends. Rising for a second straight session, the 30-share BSE Sensex rallied 760.37 points or 1.41 per cent to settle at 54,521.15. During the day, it jumped 795.88 points or 1.48 per cent to 53,760.78. The broader NSE Nifty advanced 229.30 points or 1.43 per cent to 16,278.50 as 41 of its constituents advanced.

Why Did TN Governor Omit Dr Ambedkar's Name?

Why Did TN Governor Omit Dr Ambedkar's Name?

Rediff.com10 Jan 2023

According to state government sources, not only did the governor insert some corrections, but he also initialled the final draft after those corrections had been made, reveals N Sathiya Moorthy.

Sensex falls 111 points; RIL tumbles over 7%

Sensex falls 111 points; RIL tumbles over 7%

Rediff.com1 Jul 2022

Benchmark indices settled lower on Friday, with the Sensex declining 111 points on the back of a sharp fall in index heavyweight Reliance Industries. The BSE benchmark went lower by 111.01 points or 0.21 per cent to settle at 52,907.93. During the day, it tanked 924.69 points or 1.74 per cent to 52,094.25. The NSE Nifty dipped 28.20 points or 0.18 per cent to close at 15,752.05.

Sensex ends flat in cautious trade

Sensex ends flat in cautious trade

Rediff.com20 Sep 2017

Among major gainers, ITC, Reliance Industries, Dr Reddy's and HDFC rose up to 3 per cent.

Sensex zoomed 934 points to settle at 52,532

Sensex zoomed 934 points to settle at 52,532

Rediff.com21 Jun 2022

Benchmark indices advanced for the second straight session on Tuesday, with the Sensex and Nifty jumping nearly 2 per cent each, mirroring a rally in global equity markets. Buying in index majors Reliance Industries and IT stocks buoyed the benchmarks. The BSE Sensex zoomed 934.23 points or 1.81 per cent to settle at 52,532.07. During the day, it rallied 1,201.56 points or 2.32 per cent to 52,799.40. The NSE Nifty climbed 288.65 points or 1.88 per cent to finish at 15,638.80.

Realty, auto, metal stocks drag Sensex down by 550 points

Realty, auto, metal stocks drag Sensex down by 550 points

Rediff.com18 Jan 2022

Equity benchmark Sensex plunged by 554.05 points on Tuesday, tracking deep losses in realty, auto and metal stocks amid widespread selling pressure in global markets. The 30-share index slumped by 554.05 points or 0.90 per cent to end at 60,754.86. The broader NSE Nifty fell by 195.05 points or 1.07 per cent to 18,113.05.

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

Rediff.com11 Apr 2021

These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.

Be a Medical Representative

Be a Medical Representative

Rediff.com11 May 2005

Dr Reddy's Laboratories, a global pharma company, is hiring Medical Representatives.

Sensex, Nifty advance on gains in IT, FMCG stocks

Sensex, Nifty advance on gains in IT, FMCG stocks

Rediff.com15 Nov 2021

Stock market barometers Sensex and Nifty ended marginally higher on Monday as rise in wholesale inflation capped early gains despite a positive trend in global markets. The 30-share index settled 32.02 points or 0.05 per cent higher at 60,718.71 with half of its constituents ending in green. The broad based Nifty edged up 6.70 points or 0.04 per cent to close at 18,109.45.

Sensex, Nifty soar nearly 2% on gains in RIL, Infosys

Sensex, Nifty soar nearly 2% on gains in RIL, Infosys

Rediff.com30 May 2022

Extending their rally to a third straight day, benchmark indices Sensex and Nifty jumped nearly 2 per cent on Monday on heavy buying in Reliance Industries and Infosys amid a firm trend in global equities. The 30-share BSE Sensex rallied 1,041.08 points or 1.90 per cent to settle at 55,925.74. During the day, it gained 1,197.99 points or 2.18 per cent to 56,082.65. The broader NSE Nifty jumped 308.95 points or 1.89 per cent to settle at 16,661.40.

Markets reverse early gains in volatile trade; Sensex falls 236 pts

Markets reverse early gains in volatile trade; Sensex falls 236 pts

Rediff.com24 May 2022

Equity indices failed to hold on to morning gains on Tuesday, with the Sensex falling 236 points amid a sell-off in IT stocks and weak trends from global markets. The 30-share BSE benchmark opened higher but could not carry forward the momentum and declined 236 points or 0.43 per cent to settle at 54,052.61. During the day, it hit a low of 53,886.28 and a high of 54,524.37. The broader NSE Nifty dropped 89.55 points or 0.55 per cent to end at 16,125.15.

Pharma sector seeks boost to research, innovation

Pharma sector seeks boost to research, innovation

Rediff.com3 Jul 2014

Pharma firms wants new policies that will boost investment.

Pharma sector seeks boost to research, innovation

Pharma sector seeks boost to research, innovation

Rediff.com3 Jul 2014

Pharma firms wants new policies that will boost investment.

Investors become poorer by Rs 5.78 lakh cr in two days of market fall

Investors become poorer by Rs 5.78 lakh cr in two days of market fall

Rediff.com16 Dec 2022

Investors' wealth tumbled over Rs 5.78 lakh crore in two days of market fall amid a weak trend in global markets after a host of central banks hiked interest rates and gave hawkish commentary. The 30-share BSE Sensex declined 461.22 points or 0.75 per cent to settle at 61,337.81 on Friday. In the previous trade, the BSE benchmark had tanked 878.88 points or 1.40 per cent to settle at 61,799.03.

When bears came calling, Sensex tanked 1,145 points

When bears came calling, Sensex tanked 1,145 points

Rediff.com22 Feb 2021

Dr Reddy's was the top loser in the Sensex pack, shedding around 5 per cent, followed by M&M, Tech Mahindra, Axis Bank, IndusInd Bank and TCS. NSE Nifty sank 306.05 points to finish at 14,675.70.